Carolyn Siegal has extensive business development and commercial experience in the pharmaceutical industry. Past accomplishments include:
Raised over $15 million in start-up capita
Analyzed dozens of licensing opportunities
Created early marketing programs and strategies for multiple products including the blockbusters Zithromax and Norvasc.
Prior positions as President, Janus Pharmaceuticals, SVP, Business Development, Cell-Matrix, VP Business Development, Xencor and VP, Product Development at Alpha Therapeutic. Earlier in her career, at Pfizer Inc., and Roche Laboratories she provided early commercial assessment and planning for oncology,immunology, cardiovascular, and infectious disease research programs, preclinical products and clinical stage programs. Carolyn has a MS in public health from UCLA and a BS in physical anthropology from the UC Berkeley.
SIEGAL CONSULTING
